Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mengel

Showing results (151-160 of 184) with videos related to

Pageof 19
Sort By:
Transplantation|April 28, 2016
Antibody-Mediated Rejection in a Blood Group A-Transgenic Mouse Model of ABO-Incompatible Heart TransplantationBruce Motyka, Nella Fisicaro, Szu-I Wang, et al.
Microbiology Spectrum|August 18, 2021
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 PandemicCarmen L Charlton, Leonard T Nguyen, Ashley Bailey, et al.
Transplantation Direct|March 26, 2026
The Evolution of Molecular Phenotypes Through Time in Kidney Transplant RecipientsBrigitte Baragar, Benjamin A Adam, Michael Mengel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 10, 2021
Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor-Associated Adverse EventsBenjamin A Adam, Naoka Murakami, Graeme Reid, et al.
Kidney International Reports|July 31, 2024
Relevance of the Banff Human Organ Transplant Consensus Gene Panel for Detecting Antibody and T-Cell-Mediated Rejection of Kidney AllograftsAlessia Giarraputo, Valentin Goutaudier, Blaise Robin, et al.
International Journal of Molecular Sciences|May 30, 2019
Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft RejectionLena Schiffer, Flavia Wiehler, Jan Hinrich Bräsen, et al.
Transplantation|September 26, 2003
Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication ratesPeter N Furness, Carl M Philpott, Mary T Chorbadjian, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 26, 2026
Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled studyArjang Djamali, Georg A Böhmig, Roslyn B Mannon, et al.
Trials|October 30, 2012
Rationale and design of the RIACT-study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trialLena Schiffer, Mario Schiffer, Saskia Merkel, et al.
Journal of the American Society of Nephrology : JASN|March 16, 2019
Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft SurvivalOlivier Aubert, Sarah Higgins, Yassine Bouatou, et al.
Pageof 19

Showing results (151-160 of 184) with videos related to

Sort By:
Pageof 19
Transplantation|April 28, 2016
Antibody-Mediated Rejection in a Blood Group A-Transgenic Mouse Model of ABO-Incompatible Heart TransplantationBruce Motyka, Nella Fisicaro, Szu-I Wang, et al.
Microbiology Spectrum|August 18, 2021
Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 PandemicCarmen L Charlton, Leonard T Nguyen, Ashley Bailey, et al.
Transplantation Direct|March 26, 2026
The Evolution of Molecular Phenotypes Through Time in Kidney Transplant RecipientsBrigitte Baragar, Benjamin A Adam, Michael Mengel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|July 10, 2021
Gene Expression Profiling in Kidney Transplants with Immune Checkpoint Inhibitor-Associated Adverse EventsBenjamin A Adam, Naoka Murakami, Graeme Reid, et al.
Kidney International Reports|July 31, 2024
Relevance of the Banff Human Organ Transplant Consensus Gene Panel for Detecting Antibody and T-Cell-Mediated Rejection of Kidney AllograftsAlessia Giarraputo, Valentin Goutaudier, Blaise Robin, et al.
International Journal of Molecular Sciences|May 30, 2019
Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft RejectionLena Schiffer, Flavia Wiehler, Jan Hinrich Bräsen, et al.
Transplantation|September 26, 2003
Protocol biopsy of the stable renal transplant: a multicenter study of methods and complication ratesPeter N Furness, Carl M Philpott, Mary T Chorbadjian, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|April 26, 2026
Clazakizumab in the treatment of chronic active antibody-mediated kidney transplant rejection: Results from the IMAGINE phase 3, randomized, double-blind, placebo-controlled studyArjang Djamali, Georg A Böhmig, Roslyn B Mannon, et al.
Trials|October 30, 2012
Rationale and design of the RIACT-study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trialLena Schiffer, Mario Schiffer, Saskia Merkel, et al.
Journal of the American Society of Nephrology : JASN|March 16, 2019
Archetype Analysis Identifies Distinct Profiles in Renal Transplant Recipients with Transplant Glomerulopathy Associated with Allograft SurvivalOlivier Aubert, Sarah Higgins, Yassine Bouatou, et al.
Pageof 19